talent: neoadjuvant t-dxd with or without anastrozole for her2-low, hr early stage breast cancer
Published 1 year ago • 144 plays • Length 2:59Download video MP4
Download video MP3
Similar videos
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
4:15
debbrah: t-dxd in her2 or her2-low advanced breast cancer with cns involvement
-
17:10
sabcs 2022: trio-us b-12 talent: neoadjuvant tdx with or without anastrozole for her2-low, hr e...
-
1:32
destiny-breast15: t-dxd in patients with hr hr- and her2-low or her2 ihc 0 metastatic breast cancer
-
1:59
adapt: de-escalated neoadjuvant pertuzumab trastuzumab with or without paclitaxel in hr-/her2 ebc
-
2:05
tropion-breast04: dato-dxd and durvalumab in tnbc or hr-low/her2- breast cancer
-
0:55
neoadjuvant treatment approach for her2 positive breast cancer
-
1:05
efficacy of trastuzumab deruxtecan in her2-low metastatic breast cancer
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
1:06
incorporating t-dxd in patients with her2 or her2-low bc and leptomeningeal carcinomatosis
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
-
2:49
her2-e pcr with anti-her2-based neoadjuvant therapies
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
0:29
adjuvant treatment for high risk hr breast cancer | esmo 2023 breast cancer highlights
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
1:09
the exciting new field of her2-low breast cancer
-
2:58
updated analysis of destiny-gastric02: t-dxd in her2 gej cancer who progressed with trastuzumab
-
3:01
alternate: neoadjuvant chemotherapy in er her2- breast cancer